These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 4607666

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Structural activity relationships of a series of amines injected before and after monoamine oxidase inhibitor.
    Gatgounis J.
    Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):412-20. PubMed ID: 5838346
    [No Abstract] [Full Text] [Related]

  • 24. QSAR of agents involved in serotonin and LSD binding sites.
    Chan YL, Lien EJ, Shih JC.
    NIDA Res Monogr; 1978 Apr; (22):103-13. PubMed ID: 30904
    [No Abstract] [Full Text] [Related]

  • 25. Accumulation of tritiated 5-hydroxytryptamine in brain slices.
    Ross SB, Renyl AL.
    Life Sci; 1967 Jul 01; 6(13):1407-15. PubMed ID: 4382451
    [No Abstract] [Full Text] [Related]

  • 26. Alterations of serotonin and LSD receptor binding following repeated administration of LSD.
    Trulson ME, Jacobs BL.
    Life Sci; 1979 May 28; 24(22):2053-61. PubMed ID: 459700
    [No Abstract] [Full Text] [Related]

  • 27. Cocaine and catecholamine interaction. A review.
    Smith RB.
    Arch Otolaryngol; 1973 Aug 28; 98(2):139-41. PubMed ID: 4147383
    [No Abstract] [Full Text] [Related]

  • 28. Psychoactive compounds and audiogenic seizure susceptibility.
    Boggan WO.
    Life Sci; 1973 Jul 16; 13(2):151-9. PubMed ID: 4751412
    [No Abstract] [Full Text] [Related]

  • 29. Effect of acute axotomy (spinal cord transection) on the turnover of 5-hydroxytryptamine.
    Andén NE.
    Adv Biochem Psychopharmacol; 1974 Jul 16; 10():35-43. PubMed ID: 4276958
    [No Abstract] [Full Text] [Related]

  • 30. Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.
    Fischer R, Goldman H.
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul 16; 8(4):176-84. PubMed ID: 1233520
    [Abstract] [Full Text] [Related]

  • 31. The significance of 5-hydroxytryptamine for insulin secretion in the mouse.
    Lernmark A.
    Horm Metab Res; 1971 Sep 16; 3(5):305-9. PubMed ID: 4944450
    [No Abstract] [Full Text] [Related]

  • 32. New developments in brain chemistry: catecholamine metabolism and the action of psychotropic drugs.
    Snyder SH.
    Am J Orthopsychiatry; 1967 Oct 16; 37(5):864-79. PubMed ID: 4861482
    [No Abstract] [Full Text] [Related]

  • 33. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets.
    Pletscher A.
    Br J Pharmacol Chemother; 1968 Jan 16; 32(1):1-16. PubMed ID: 4870578
    [No Abstract] [Full Text] [Related]

  • 34. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E.
    Neuropsychopharmacology; 2005 Sep 16; 30(9):1693-702. PubMed ID: 15756304
    [Abstract] [Full Text] [Related]

  • 35. [Studies on the significance of amine binding for the development of blood pressure tolerance].
    Pohle W, Matthies H.
    Acta Biol Med Ger; 1967 Sep 16; 19(1):99-110. PubMed ID: 5589010
    [No Abstract] [Full Text] [Related]

  • 36. Dopamine receptors: a review.
    Woodruff GN.
    Comp Gen Pharmacol; 1971 Dec 16; 2(8):439-55. PubMed ID: 4147044
    [No Abstract] [Full Text] [Related]

  • 37. Drugs and sleep.
    Oswald I.
    Pharmacol Rev; 1968 Dec 16; 20(4):273-303. PubMed ID: 4305226
    [No Abstract] [Full Text] [Related]

  • 38. [Neurobiologic aspects of the morphine addictions].
    Herz A, Bläsig J.
    Naturwissenschaften; 1974 Jun 16; 61(6):223-8. PubMed ID: 4603708
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.